Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jedd Wolchok

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Lancet. Oncology|March 1, 2023
Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshopLalitha K Shankar, Heiko Schöder, Elad Sharon, et al.
Nature Immunology|July 31, 2019
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Immunology|September 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
The Journal of Clinical Investigation|February 9, 2016
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanomaNicolas Jacquelot, David P Enot, Caroline Flament, et al.
Nature|May 19, 2022
Neoantigen quality predicts immunoediting in survivors of pancreatic cancerMarta Łuksza, Zachary M Sethna, Luis A Rojas, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trialsHolbrook E Kohrt, Paul C Tumeh, Don Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2018
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation SequencingHira Rizvi, Francisco Sanchez-Vega, Konnor La, et al.
Nature Genetics|April 6, 2023
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancerArvind Ravi, Matthew D Hellmann, Monica B Arniella, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Lancet. Oncology|March 1, 2023
Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshopLalitha K Shankar, Heiko Schöder, Elad Sharon, et al.
Nature Immunology|July 31, 2019
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Immunology|September 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
The Journal of Clinical Investigation|February 9, 2016
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanomaNicolas Jacquelot, David P Enot, Caroline Flament, et al.
Nature|May 19, 2022
Neoantigen quality predicts immunoediting in survivors of pancreatic cancerMarta Łuksza, Zachary M Sethna, Luis A Rojas, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trialsHolbrook E Kohrt, Paul C Tumeh, Don Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2018
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation SequencingHira Rizvi, Francisco Sanchez-Vega, Konnor La, et al.
Nature Genetics|April 6, 2023
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancerArvind Ravi, Matthew D Hellmann, Monica B Arniella, et al.
Pageof 4